Shanghai Fosun Pharmaceutical Group Co Ltd (600196) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.038x

Based on the latest financial reports, Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a cash flow conversion efficiency ratio of 0.038x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥2.40 Billion ≈ $350.75 Million USD) by net assets (CN¥62.49 Billion ≈ $9.14 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Shanghai Fosun Pharmaceutical Group Co L's balance sheet to measure how much of total assets are equity-financed.

Shanghai Fosun Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Shanghai Fosun Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Shanghai Fosun Pharmaceutical Group Co L's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Shanghai Fosun Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fosun Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suzhou Everbright Photonics Co. Ltd. A SHG:688048	-0.001x
Aurubis AG XETRA:NDA	0.001x
Shanghai Zhangjiang Hi-Tech Park Development Co Ltd SHG:600895	0.028x
The Gap, Inc. NYSE:GAP	0.058x
Torrent Power Limited NSE:TORNTPOWER	0.130x
Pegatron Corp TW:4938	0.089x
Valley National Bancorp NASDAQ:VLY	0.025x
Beijer Ref AB (publ) ST:BEIJ-B	0.028x

Annual Cash Flow Conversion Efficiency for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fosun Pharmaceutical Group Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Fosun Pharmaceutical Group Co L stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥62.49 Billion ≈ $9.14 Billion	CN¥6.01 Billion ≈ $878.76 Million	0.096x	+28.64%
2024-12-31	CN¥59.93 Billion ≈ $8.77 Billion	CN¥4.48 Billion ≈ $655.12 Million	0.075x	-3.07%
2023-12-31	CN¥56.62 Billion ≈ $8.28 Billion	CN¥4.36 Billion ≈ $638.48 Million	0.077x	-1.13%
2022-12-31	CN¥54.11 Billion ≈ $7.92 Billion	CN¥4.22 Billion ≈ $617.16 Million	0.078x	-4.51%
2021-12-31	CN¥48.38 Billion ≈ $7.08 Billion	CN¥3.95 Billion ≈ $577.83 Million	0.082x	+45.50%
2020-12-31	CN¥45.98 Billion ≈ $6.73 Billion	CN¥2.58 Billion ≈ $377.50 Million	0.056x	-31.75%
2019-12-31	CN¥39.20 Billion ≈ $5.74 Billion	CN¥3.22 Billion ≈ $471.54 Million	0.082x	-6.40%
2018-12-31	CN¥33.59 Billion ≈ $4.92 Billion	CN¥2.95 Billion ≈ $431.69 Million	0.088x	+1.23%
2017-12-31	CN¥29.74 Billion ≈ $4.35 Billion	CN¥2.58 Billion ≈ $377.57 Million	0.087x	+3.82%
2016-12-31	CN¥25.25 Billion ≈ $3.69 Billion	CN¥2.11 Billion ≈ $308.77 Million	0.084x	+6.55%
2015-12-31	CN¥20.67 Billion ≈ $3.02 Billion	CN¥1.62 Billion ≈ $237.21 Million	0.078x	+24.82%
2014-12-31	CN¥19.10 Billion ≈ $2.80 Billion	CN¥1.20 Billion ≈ $175.63 Million	0.063x	+9.71%
2013-12-31	CN¥17.66 Billion ≈ $2.58 Billion	CN¥1.01 Billion ≈ $148.03 Million	0.057x	+31.70%
2012-12-31	CN¥15.30 Billion ≈ $2.24 Billion	CN¥665.52 Million ≈ $97.39 Million	0.043x	+56.15%
2011-12-31	CN¥11.37 Billion ≈ $1.66 Billion	CN¥316.65 Million ≈ $46.34 Million	0.028x	+28.63%
2010-12-31	CN¥9.39 Billion ≈ $1.37 Billion	CN¥203.36 Million ≈ $29.76 Million	0.022x	-42.52%
2009-12-31	CN¥6.95 Billion ≈ $1.02 Billion	CN¥261.87 Million ≈ $38.32 Million	0.038x	-28.14%
2008-12-31	CN¥4.45 Billion ≈ $650.58 Million	CN¥233.04 Million ≈ $34.10 Million	0.052x	+72.08%
2007-12-31	CN¥4.32 Billion ≈ $631.62 Million	CN¥131.48 Million ≈ $19.24 Million	0.030x	-39.90%
2006-12-31	CN¥3.65 Billion ≈ $533.90 Million	CN¥184.91 Million ≈ $27.06 Million	0.051x	-22.64%
2005-12-31	CN¥2.88 Billion ≈ $420.71 Million	CN¥188.35 Million ≈ $27.56 Million	0.066x	-10.12%
2004-12-31	CN¥2.81 Billion ≈ $411.75 Million	CN¥205.10 Million ≈ $30.01 Million	0.073x	-2.08%
2003-12-31	CN¥2.02 Billion ≈ $295.14 Million	CN¥150.14 Million ≈ $21.97 Million	0.074x	+21.56%
2002-12-31	CN¥1.67 Billion ≈ $244.87 Million	CN¥102.47 Million ≈ $15.00 Million	0.061x	+18.84%
2001-12-31	CN¥1.32 Billion ≈ $193.54 Million	CN¥68.15 Million ≈ $9.97 Million	0.052x	-54.64%
2000-12-31	CN¥1.22 Billion ≈ $178.30 Million	CN¥138.43 Million ≈ $20.26 Million	0.114x	+95.42%
1999-12-31	CN¥657.08 Million ≈ $96.15 Million	CN¥38.20 Million ≈ $5.59 Million	0.058x	-53.64%
1998-12-31	CN¥530.77 Million ≈ $77.67 Million	CN¥66.55 Million ≈ $9.74 Million	0.125x	--

About Shanghai Fosun Pharmaceutical Group Co Ltd

SHG:600196 China Drug Manufacturers - Specialty & Generic

Market Cap

$7.36 Billion

CN¥50.31 Billion CNY

Market Cap Rank

#2789 Global

#354 in China

Share Price

CN¥23.75

Change (1 day)

+4.35%

52-Week Range

CN¥21.21 - CN¥32.15

All Time High

CN¥85.06